Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New sequence-specific human ribonuclease: purification and properties

G Przewlocki1, J Lipecka, A Edelman

  • 1Institut National de la Santé et de la Recherche Médicale Unité 467, Centre Hospitalier Universitaire Necker,75015 Paris, France. greg@nencki.gov.pl

Nucleic Acids Research
|August 15, 1998
PubMed
Summary

Researchers discovered RNase T84, a novel sequence-specific enzyme from human colon cancer cells. This endonuclease shows unique cleavage patterns and is highly expressed in colon carcinoma cell lines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latinx Patients' Perceptions of Culturally Sensitive Health Care and their Association with Patient Satisfaction, Patient-Provider Communication, and Therapeutic Alliance.

Journal of racial and ethnic health disparities·2021
Same author

Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.

BMC medicine·2018
Same author

Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation.

Data in brief·2016
Same author

Changes in lipid raft proteome upon TNF-α stimulation of cystic fibrosis cells.

Journal of proteomics·2016
Same author

Notes from the field: expanding abortion services into the second trimester of pregnancy in Nepal (2007-2012).

Contraception·2014
Same author

Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity.

Gene therapy·2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Ribonucleases (RNases) play crucial roles in RNA metabolism.
  • Understanding sequence-specific RNases is vital for cellular processes and disease research.
  • Human colon carcinoma cells are a source of novel enzymes with potential biological significance.

Purpose of the Study:

  • To isolate and characterize a new sequence-specific RNase from human colon carcinoma T84 cells.
  • To determine the enzymatic properties, substrate specificity, and expression pattern of the novel RNase.
  • To investigate the potential role of this enzyme in colon cancer.

Main Methods:

  • Purification of the enzyme using pH precipitation, HiTrapSP, and Superdex 200 FPLC.
  • Determination of molecular weight and enzymatic activity assays.

Related Experiment Videos

  • Analysis of substrate specificity using synthetic ribohomopolymers and heteroribopolymers.

    • Main Results:

    • A 19 kDa sequence-specific endonuclease, named RNase T84, was purified.
    • RNase T84 cleaves phosphodiester bonds at AU or GU steps, with minimal sequence requirement of 5'AU3' or 5'GU3'.
    • The enzyme efficiently hydrolyzes poly(I), poly(A,U), and poly(A,G,U), but poorly hydrolyzes homoribopolymers like poly(A), poly(G), poly(U), and poly(C).
    • RNase T84 activity is higher in colon carcinoma cell lines compared to other epithelial cell lines.
    • The gene for RNase T84 is abundantly expressed in human colon carcinoma cell lines.

    Conclusions:

    • RNase T84 is a newly identified sequence-specific RNase with unique substrate preferences.
    • Its distinct activity and abundant expression in colon carcinoma suggest a potential role in the disease.
    • Further research into RNase T84 could offer insights into colon cancer biology and therapeutic targets.